SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2190910

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2190910

U.S. Telemedicine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The U.S. telemedicine market reached USD 35.9 billion in 2025 and is projected to grow at a CAGR of 16% from 2026 to 2035. The market is expected to cross USD 155.93 billion valuation by 2035. Virtual delivery includes consultations, monitoring, asynchronous care, and integrated platforms used by providers, payers, and patients. Commercial performance depends on clinical access and continuing workflows, making reimbursement, interoperability, security, and the ability to connect digital and in-person care relevant alongside the availability of video or messaging technology.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$35.9 Billion
Forecast Value$155.93 Billion
CAGR16%

Behavioral-health workforce shortages support remote access where travel, scheduling, and fragmented local networks delay treatment. Suppliers compete for roles within health-plan networks, employer benefits, and referral pathways because clinical capacity remains a constrained resource. Medicare participation also supports longer-term investment in platforms that connect scheduling, records, engagement, and monitoring. AI documentation assistance, triage, and asynchronous tools can reduce administrative work around encounters and improve the viability of services with limited clinical time available. These drivers favor coordinated care models, allowing customers to assess virtual delivery through its fit with reimbursement, clinician resources, and continuing patient-management requirements rather than the availability of a communication tool alone. Dependable reimbursement also lets health systems consider integrated specialty programs through multi-year infrastructure investments.

Hardware generated USD 7.18 billion in 2025. Diagnostic peripherals, home-monitoring devices, and clinical communication equipment support pathways that require physiological data or specialist oversight beyond an ordinary remote visit. Chronic-care and post-acute programs increasingly influence the device requirement. Suppliers need to connect equipment reliably with the clinical systems and review processes through which staff use the information. The segment's commercial proposition therefore combines the device with integration and support, allowing providers to establish recurring patient-management services rather than simply distribute connected hardware. A suitable product must fit the actual care model and the resources available to monitor and respond to patients over time.

Psychiatry generated USD 7.90 billion in 2025. A mismatch between mental-health demand and licensed clinical capacity supports virtual services across payer, employer, and provider channels. Many consultations can take place through recurring remote engagement, giving the specialty a practical route to continued care. Suppliers still need appropriate recruitment, prescribing workflows, clinical governance, and connections with broader care management. The commercial role consequently extends beyond appointment access. Purchasers evaluate the provider network, quality, and continuity required to sustain treatment, making a coordinated clinical service more valuable than a general-purpose video encounter offered without the supporting systems needed for ongoing behavioral-health care.

Teladoc Health held a 5.8% market share in 2025. Its activities span virtual consultations, behavioral health, chronic-condition support, and enterprise relationships with plans and employers. Combining member access, clinical services, and payer integration can suit buyers seeking more coordinated capabilities through fewer vendors. Competitors approach the market through care-enablement software, connected monitoring, specialty coverage, or enterprise workflows. Teladoc's position reflects that breadth within a fragmented supplier landscape. Continuing differentiation depends on whether access, clinical delivery, and integration fit the purchaser's program, allowing virtual services to operate within care pathways that also include referrals, documentation, monitoring, and appropriate in-person follow-up.

Some of the major players in this market are AMC Health, AMD Global Telemedicine, American Well (Amwell), Cisco Systems, Eagle Telemedicine, GE Healthcare, Health Catalyst, HIPAAVideo.net, Honeywell International, Koninklijke Philips N.V., Masimo Corporation, McKesson Medical-Surgical, Mend, Oracle Corporation (Cerner), RemetricHealth, SOC Telemed (Patient Square Capital), Specialist Telemed, Updox, VCDoctor, and Veradigm LLC (Allscripts Healthcare Solutions). Their roles include clinical networks, monitoring services, diagnostic equipment, command centers, communications, data intelligence, and provider workflows. This variety reflects the technical and operational requirements of different virtual-care programs, with suppliers competing through specialist expertise and compatibility with established healthcare systems as well as patient-facing access.

Product Code: 4362

Table of Contents

Chapter 1. Research Methodology

  • 1.1 Research approach
  • 1.2 Quality Commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research Trail & Confidence Scoring
    • 1.3.1 Research Trail Components
    • 1.3.2 Scoring Components
  • 1.4 Data Collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Component trends
    • 2.2.2 Specialty area trends
    • 2.2.3 End use trends
    • 2.2.4 Regional trends
  • 2.3 TAM analysis, 2027-2035
  • 2.4 CXO perspectives: strategic imperatives

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Cost structure
    • 3.1.4 Value addition at each stage
    • 3.1.5 Factors affecting the value chain
    • 3.1.6 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of chronic diseases
      • 3.2.1.2 Advances in digital health technologies
      • 3.2.1.3 Favorable regulations and reimbursement policies
      • 3.2.1.4 Increased demand for convenient remote healthcare access
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Data privacy and connectivity issues
      • 3.2.2.2 Stringent regulatory policies
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Pricing analysis (Driven by Primary Research)
    • 3.4.1 Historical price trend analysis
    • 3.4.2 Pricing strategy by player type (Premium / Value / Cost-plus)
  • 3.5 Regulatory landscape
    • 3.5.1 Federal regulatory framework (FDA, CMS, FCC)
    • 3.5.2 State-level telehealth regulations & licensure
    • 3.5.3 Reimbursement & payer policies
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Trade data analysis (Based on Paid Database)
    • 3.8.1 Import/Export volume & value trends
    • 3.8.2 Key trade corridors & tariff impact
  • 3.9 Impact of AI & Generative AI on the market (Driven by Primary Research)
    • 3.9.1 AI-driven disruption of existing business models
    • 3.9.2 GenAI use cases & adoption roadmap by segment
    • 3.9.3 Risks, limitations & regulatory considerations
  • 3.10 Patent / IP landscape
  • 3.11 Medical infrastructure landscape
  • 3.12 Epidemiology / disease burden

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 Market concentration analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Key developments
    • 4.5.1 Mergers & acquisitions
    • 4.5.2 Partnerships & collaborations
    • 4.5.3 New product launches
    • 4.5.4 Expansion plans and funding
  • 4.6 Company tier benchmarking
    • 4.6.1 Tier classification criteria & qualifying thresholds
    • 4.6.2 Tier positioning matrix by revenue, geography & innovation

Chapter 5. Market Estimates and Forecast, By Component, 2022-2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hardware
  • 5.3 Software
    • 5.3.1 Cloud-based
    • 5.3.2 On-premises
  • 5.4 Services
    • 5.4.1 Tele-consultation
    • 5.4.2 Tele-monitoring
    • 5.4.3 Tele-education/training
    • 5.4.4 Other services

Chapter 6. Market Estimates and Forecast, By Specialty Area, 2022-2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Pulmonary
  • 6.3 Psychiatry
  • 6.4 Cardiology
  • 6.5 Endocrinology
  • 6.6 Rheumatology
  • 6.7 Gynecology
  • 6.8 Gastroenterology
  • 6.9 Oncology
  • 6.10 Other specialty areas

Chapter 7. Market Estimates and Forecast, By End Use, 2022-2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Healthcare providers
    • 7.2.1 Hospitals and clinics
    • 7.2.2 Long-term care centers
    • 7.2.3 Other healthcare providers
  • 7.3 Payers
  • 7.4 Patients
  • 7.5 Other end use

Chapter 8. Company Profiles

  • 8.1 AMC Health
  • 8.2 AMD Global Telemedicine
  • 8.3 American Well (Amwell)
  • 8.4 Cisco Systems
  • 8.5 Eagle Telemedicine
  • 8.6 GE Healthcare
  • 8.7 Health Catalyst
  • 8.8 HIPAAVideo.net
  • 8.9 Honeywell International
  • 8.10 Koninklijke Philips N.V.
  • 8.11 Masimo Corporation
  • 8.12 McKesson Medical-Surgical
  • 8.13 Mend
  • 8.14 Oracle Corporation (Cerner)
  • 8.15 RemetricHealth
  • 8.16 SOC Telemed (Patient Square Capital)
  • 8.17 Specialist Telemed
  • 8.18 Teladoc Health
  • 8.19 Updox
  • 8.20 VCDoctor
  • 8.21 Veradigm LLC (Allscripts Healthcare Solutions)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!